247 related articles for article (PubMed ID: 30113762)
1. Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment.
Almståhl A; Skoogh Andersson J; Alstad T; Fagerberg-Mohlin B; Finizia C
Int J Dent Hyg; 2019 Feb; 17(1):46-54. PubMed ID: 30113762
[TBL] [Abstract][Full Text] [Related]
2. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
Braam PM; Roesink JM; Raaijmakers CP; Busschers WB; Terhaard CH
Radiat Oncol; 2007 Jan; 2():3. PubMed ID: 17207274
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
5. Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes.
Likhterov I; Ru M; Ganz C; Urken ML; Chai R; Okay D; Liu J; Stewart R; Culliney B; Palacios D; Lazarus CL
Laryngoscope; 2018 Dec; 128(12):2732-2739. PubMed ID: 30325025
[TBL] [Abstract][Full Text] [Related]
6. Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy.
Lal P; Nautiyal V; Verma M; Yadav R; Maria Das KJ; Kumar S
J Cancer Res Ther; 2018; 14(6):1196-1201. PubMed ID: 30488829
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
9. Whole saliva physico-biochemical changes and quality of life in head and neck cancer patients following conventional radiation therapy: a prospective longitudinal study.
Tiwana MS; Mahajan MK; Uppal B; Koshy G; Sachdeva J; Lee HN; Talole SD
Indian J Cancer; 2011; 48(3):289-95. PubMed ID: 21921325
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Bian X; Song T; Wu S
Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
[TBL] [Abstract][Full Text] [Related]
11. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy.
Palma LF; Gonnelli FAS; Marcucci M; Dias RS; Giordani AJ; Segreto RA; Segreto HRC
Lasers Med Sci; 2017 May; 32(4):827-832. PubMed ID: 28258315
[TBL] [Abstract][Full Text] [Related]
12. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
13. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
15. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09.
Fisher J; Scott C; Scarantino CW; Leveque FG; White RL; Rotman M; Hodson DI; Meredith RF; Foote R; Bachman DG; Lee N
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):832-6. PubMed ID: 12788192
[TBL] [Abstract][Full Text] [Related]
16. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial.
Louzeiro GC; Cherubini K; de Figueiredo MAZ; Salum FG
J Photochem Photobiol B; 2020 Aug; 209():111933. PubMed ID: 32570059
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.
Bajwa HK; Singareddy R; Alluri KR
Brachytherapy; 2016; 15(3):381-386. PubMed ID: 26947320
[TBL] [Abstract][Full Text] [Related]
18. The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT.
Yuce Sari S; Yazici G; Yuce D; Karabulut E; Cengiz M; Ozyigit G
Clin Nutr ESPEN; 2016 Dec; 16():30-35. PubMed ID: 28531452
[TBL] [Abstract][Full Text] [Related]
19. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
[TBL] [Abstract][Full Text] [Related]
20. The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
Lin A; Helgeson ES; Treister NS; Schmidt BL; Patton LL; Elting LS; Lalla RV; Brennan MT; Sollecito TP
Oral Oncol; 2022 Apr; 127():105783. PubMed ID: 35231809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
